Autism Spectrum Disorder Therapeutics Market

1. Autism Spectrum Disorder Therapeutics Market Size, Share, Top Vendors, Industry Trends, Growth, Recent Developments, Technology Forecast to 2028 A neurological ailment called autism spectrum disorder (ASD) is linked to and frequently co-occurs with other medical conditions such seizures, recurrent infections, sleep problems, anxiety, depression, and digestive issues. Only thorough and developmental tests can identify ASD. Between the ages of 18 months and 2 years, it is detectable. Aripiprazole, Risperidone, and Melatonin are examples of medications that have received FDA approval and are used to treat ASD. The medications being tested in clinical settings for their safety and effectiveness in the treatment of ASD are bumetanide and balovaptan. To know about the Research Methodology OfAutism Spectrum Disorder Therapeutics Market Request Sample Report: Business Dynamics: The market for therapies for autism spectrum disorders (ASD) is anticipated to rise as ASD becomes more prevalent globally. For instance, 62 million people globally were predicted to have ASD in 2022, according to data from Our World in Data published in 2017. Furthermore, fewer than 50 million of these cases involved men. About 18 million of the 62 million people with ASD exclusively had Autism, while 44 million also had Asperger syndrome and other spectrum illnesses. The market for treatments for autism spectrum disorders, however, may be hampered by the strict rules and ongoing oversight used by regulatory bodies for product approval and marketing of pharmaceuticals. For instance, the U.S. Food and Drug Administration (FDA) shut down operations of Pick and Pay Inc. Cili Minerals, a manufacturer of drugs and dietary supplements with headquarters in Louisiana, in May 2017 after discovering that the business was misrepresenting the capabilities of its products to treat autism. Key features of the study:  This report provides in-depth analysis of the autism spectrum disorder therapeutics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2027, considering 2018 as the base year  It elucidates potential revenue opportunity across different segments and explains attractive investment propo- sition matrix for this market  This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players  It profiles key players in the global autism spectrum disorder therapeutics market based on the following param- eters – company overview, financial performance, product portfolio, geographical presence, distribution strate- gies, key developments, and strategies

2.  Key players covered as a part of this study include, F. Hoffmann-La Roche AG, Neurim Pharmaceuticals, Inc., Yamo Pharmaceuticals LLC, Servier Laboratories Ltd., Otsuka Holdings Co. Ltd., Curemark LLC, Oryzon Genomics S.A., GW Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Zynerba Pharmaceuticals Inc., Stalicla SA., Novartis AG, Pfizer, Inc., and Bristol Myers Squibb  Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, mar- ket expansion, and marketing tactics  The global autism spectrum disorder therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Autism Spectrum Disorder Therapeu- tics market, research and consulting firms, new entrants, and financial analysts Get PDF Overlook Of Autism Spectrum Disorder Therapeutics Market Detailed Segmentation:  Global Autism Spectrum Disorder Therapeutics Market, By Drug Type: oAripiprazole oRisperidone oMelatonin oCM-AT oBumetanide oBalovaptan  Global Autism Spectrum Disorder Therapeutics Market, By Age Group: oChild oAdult  Global Autism Spectrum Disorder Therapeutics Market, By Distribution Channel: oHospital Pharmacies oRetail Pharmacies oOnline Pharmacies Table of Contents 1.Research Objective and Assumption oResearch Objectives

3. oAssumptions oAbbreviations 2.Market Overview oReport Description  Market Definition and Scope oExecutive Summary  Market Snippet, By Drug Type  Market Snippet, By Age Group  Market Snippet, By Distribution Channel  Market Snippet, By Region oCoherent Opportunity Map (COM) 3.Market Dynamics, Regulations, and Trends Analysis oMarket Dynamics  Drivers  Restraints  Market Opportunities oImpact Analysis oMarket Trends oKey Developments oRegulatory Landscape oCollaborations & Partnerships oEpidemiology Analysis oPipeline Analysis & Approved Product Analysis oRegulatory Scenario oReimbursement Scenario 4.Global Autism Spectrum Disorder Therapeutics Market, By Drug Class, 2022 – 2028, (US$ Million) oIntroduction  Market Share Analysis, 2022 and 2028 (%)

4.  Y-o-Y Growth Analysis, 2022 – 2028  Segment Trends oAripiprazole  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2022 – 2028, (US$ Million) oRisperidone  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2022 – 2028, (US$ Million) oMelatonin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2022 – 2028, (US$ Million) oCM-AT  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2022 – 2028, (US$ Million) oBumetanide  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2022 – 2028, (US$ Million) oBalovaptan  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2022 – 2028, (US$ Million) Purchase This Premium Report With Flat USD 2000 OFF About US: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defence, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable

5. results for our clients. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027